Page last updated: 2024-08-25

rosiglitazone and Acute Disease

rosiglitazone has been researched along with Acute Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (84.62)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabay, RJ; Castellanos, KJ; Fantuzzi, G; Malecki, EA1
Divine, G; Habib, ZA; Havstad, SL; Krajenta, R; Lanfear, DE; Pladevall, M; Tang, J; Tzogias, L; Wells, K; Williams, LK1
Chen, C; Feng, JR; Hao, SX; Wang, WX; Yan, H1
Chen, HO; Fu, A; Xie, YT1
Li, LJ; Xu, RL1
Khanduja, KL; Malhotra, S; Pandhi, P; Sidhu, S; Vaiphei, K1
Aburatani, H; Blumberg, RS; Kadowaki, T; Matsuhashi, N; Nagai, R; Nakajima, A; Saubermann, LJ; Terauchi, Y; Wada, K; Zhao, S1
Britti, D; Caputi, AP; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C1
Castledine, C; Kingdon, E; Wright, D1
Barthet, M; Closa, D; Folch-Puy, E; Granell, S; Iovanna, JL1
de la Lastra, CA; Martín, AR; Sánchez-Hidalgo, M; Villegas, I1
Chen, P; Deng, JW; Huang, L; Wang, WJ; Xiang, XD1
Baran, R; Bhattacharya, M; Gerrits, CM; Kupfer, S; Manthena, S; Perez, A1

Other Studies

13 other study(ies) available for rosiglitazone and Acute Disease

ArticleYear
Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice.
    Pancreas, 2014, Volume: 43, Issue:6

    Topics: Acute Disease; Animals; Anti-Obesity Agents; Benzoxazines; Interleukin-12; Interleukin-18; Lactones; Male; Mice, Inbred C57BL; Obesity; Orlistat; Pancreatitis; Piperidines; Receptors, CCR2; Rosiglitazone; Severity of Illness Index; Thiazolidinediones; Treatment Failure; Vasodilator Agents

2014
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.
    Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:6

    Topics: Acute Disease; Cardiovascular Diseases; Cohort Studies; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Pioglitazone; Proportional Hazards Models; Retrospective Studies; Rosiglitazone; Stroke; Thiazolidinediones; Treatment Outcome

2009
[The effect of rosiglitazone on the activity of STAT1 in rats with severe acute pancreatitis].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2009, Feb-01, Volume: 47, Issue:3

    Topics: Acute Disease; Animals; Disease Models, Animal; Male; Pancreas; Pancreatitis; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; STAT1 Transcription Factor; Thiazolidinediones

2009
[Study on the protective effect and related mechanisms of Rosiglitazone on acute hepatic failure in mice].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:7

    Topics: Acute Disease; Animals; Apoptosis; Aspartate Aminotransferases; Caspase 3; Disease Models, Animal; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2009
[The effect of Rosiglitazone, a PPARgamma receptor agonist, on the NF-kappaB signaling pathway in acute hepatic injury induced by LPS].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:12

    Topics: Acute Disease; Animals; Blotting, Western; Disease Models, Animal; I-kappa B Proteins; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; NF-kappa B; NF-kappa B p50 Subunit; PPAR gamma; Random Allocation; Rosiglitazone; Signal Transduction; Thiazolidinediones

2009
Rosiglitazone promotes pancreatic regeneration in experimental model of acute pancreatitis.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:2

    Topics: Acute Disease; Animals; Arginine; Disease Models, Animal; DNA; Female; Male; Pancreatitis; PPAR gamma; Rats; Rats, Wistar; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Severity of Illness Index; Sincalide; Thiazolidinediones; Time Factors

2011
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
    Inflammatory bowel diseases, 2002, Volume: 8, Issue:5

    Topics: Acute Disease; Animals; Antibody Formation; Antioxidants; Chromans; Colitis; Cytokines; Disease Models, Animal; Hypoglycemic Agents; Ligands; Mice; Mice, Inbred C57BL; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Th2 Cells; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2002
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
    Intensive care medicine, 2004, Volume: 30, Issue:5

    Topics: Acute Disease; Amylases; Animals; Cell Adhesion Molecules; Ceruletide; Lipase; Lipid Peroxidation; Male; Mice; Pancreatitis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors

2004
Rosiglitazone as a cause of acute interstitial nephritis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:7

    Topics: Acute Disease; Fibrinolytic Agents; Humans; Kidney; Male; Middle Aged; Nephritis, Interstitial; Rosiglitazone; Thiazolidinediones; Time Factors

2006
Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.
    World journal of gastroenterology, 2006, Oct-28, Volume: 12, Issue:40

    Topics: Acute Disease; Animals; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Lipase; Liver; Male; NF-kappa B; Nitric Oxide Synthase Type II; Pancreatitis; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Severity of Illness Index; Thiazolidinediones

2006
Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    European journal of pharmacology, 2007, May-21, Volume: 562, Issue:3

    Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Colitis, Ulcerative; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Hypoglycemic Agents; Immunoblotting; Inflammation; Male; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor RelA; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2007
[Effect of rosiglitazone on the expression of T-bet/GATA-3 in T lymphocytes in patients with acute asthma].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2007, Volume: 30, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Asthma; Case-Control Studies; Dexamethasone; Female; GATA3 Transcription Factor; Humans; Interferon-gamma; Interleukin-4; Male; Middle Aged; Rosiglitazone; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Thiazolidinediones; Young Adult

2007
A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.
    Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:10

    Topics: Acute Disease; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus, Type 2; Female; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Retrospective Studies; Rosiglitazone; Thiazolidinediones

2007